The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5Huiping Shuai, Hin Chu, Jasper Fuk‐Woo Chan et al.|EBioMedicine|2023Cited by 57
Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: real-world study in Jilin Province, ChinaHongqin Xu, Junqi Niu, Huazhong Zhao et al.|Emerging Microbes & Infections|2022Cited by 32
Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tractBingjie Hu, Hin Chu, Jasper Fuk‐Woo Chan et al.|EBioMedicine|2023Cited by 22
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivoHuiping Shuai, Hin Chu, Jingxin Qiao et al.|Nature Communications|2025Cited by 8
N460S in PB2 and I163T in nucleoprotein synergistically enhance the viral replication and pathogenicity of influenza B virusYang Wang, Weiqi Pan|PLoS Pathogens|2025Cited by 2